Latest Regulatory Approval News

Paradigm Biopharmaceuticals has launched a Loyalty and Piggyback Options program aimed at rewarding shareholders and raising up to $111.96 million to support its pivotal Phase III clinical trial.

Classic Minerals Limited has agreed to sell its Kat Gap gold tenements to Bain Global Resources for A$7 million, aiming to reduce debt and refocus on other exploration projects. The deal awaits shareholder approval and regulatory clearances.

LCL Resources has executed a binding agreement to divest its Colombian assets for A$10 million, while confirming a significant copper-gold porphyry discovery at its Dada project in Papua New Guinea.

Alligator Energy reports significant progress across its uranium portfolio, including regulatory milestones at Samphire and promising drilling results at Big Lake and Nabarlek North, supported by a solid cash position of $20.2 million.

Mindax Limited progresses its Mid-West Shared Infrastructure Project and seeks development partners for the Mt Forrest Iron Project, while securing a significant R&D tax incentive refund.

Triton Minerals has secured A$17 million from the sale of a 70% stake in its Mozambique graphite assets, while progressing environmental approvals and unveiling promising high-grade gold and copper results at its new Aucu project.

Echo IQ confirms the material significance of its pre-submission FDA meeting for EchoSolv HF, marking a pivotal step toward US market entry and commercialisation.

Cambium Bio has secured a A$3 million capital raise and achieved FDA Fast Track status for its lead ophthalmology product, Elate Ocular®, setting the stage for Phase 3 trials in mid-2025.

Kaili Resources has streamlined its exploration portfolio by divesting high-cost, low-return tenements and is intensifying efforts in rare earths and precious metals exploration, targeting promising projects in South Australia and Western Australia.

Renascor Resources advances its Battery Anode Material project with the Early Contractor Involvement phase nearing completion, alongside securing major project status and progressing its Purified Spherical Graphite demonstration plant.

Macro Metals Limited accelerates its transformation into a diversified mining services company through a $4 million strategic placement, a majority Indigenous-owned joint venture, and key asset acquisitions in Western Australia.

Emyria Limited reports strong progress in its MDMA and psilocybin-assisted therapy programs alongside a successful $2.525 million capital raise, positioning the company for expanded mental health treatment services.